» Articles » PMID: 7678300

Sulfated Polyanion Inhibition of Scrapie-associated PrP Accumulation in Cultured Cells

Overview
Journal J Virol
Date 1993 Feb 1
PMID 7678300
Citations 143
Authors
Affiliations
Soon will be listed here.
Abstract

The accumulation of an abnormal, protease-resistant form of the protein PrP (PrP-res) in hosts with scrapie and related transmissible spongiform encephalopathies appears to be important in disease pathogenesis. To gain insight into the mechanism of PrP-res accumulation and the in vivo antiscrapie activity of certain polyanions, we have studied effects of sulfated glycans on PrP metabolism in scrapie-infected neuroblastoma cells. Pentosan polysulfate, like the amyloid-binding dye Congo red, potently inhibited the accumulation of PrP-res in these cells without apparent effects on the metabolism of the normal isoform. The inhibition was due primarily to prevention of new PrP-res accumulation rather than destabilization of preexisting PrP-res. PrP-res accumulation remained depressed in the cultures after removal of the inhibitors. The activities of other sulfated glycans, nonsulfated polyanions, dextran, and DEAE-dextran were compared with those of pentosan polysulfate and Congo red. This comparison provided evidence that the density of sulfation and molecular size are factors influencing anti-PrP-res activity of sulfated glycans. The relative potencies of these compounds corresponded well with their previously determined antiscrapie activities in vivo, suggesting that the prophylactic effects of sulfated polyanions may be due to inhibition of PrP-res accumulation. Since PrP-res amyloid is known to contain sulfated glycosaminoglycans, we reason that these inhibitors may competitively block an interaction between PrP and endogenous glycosaminoglycans that is essential for its accumulation in a protease-resistant, potentially amyloidogenic state.

Citing Articles

Brain Organoids: A Game-Changer for Drug Testing.

Giorgi C, Lombardozzi G, Ammannito F, Scenna M, Maceroni E, Quintiliani M Pharmaceutics. 2024; 16(4).

PMID: 38675104 PMC: 11054008. DOI: 10.3390/pharmaceutics16040443.


Neuronal Ndst1 depletion accelerates prion protein clearance and slows neurodegeneration in prion infection.

Aguilar-Calvo P, Malik A, Sandoval D, Barback C, Orru C, Standke H PLoS Pathog. 2023; 19(9):e1011487.

PMID: 37747931 PMC: 10586673. DOI: 10.1371/journal.ppat.1011487.


A tetracationic porphyrin with dual anti-prion activity.

Masone A, Zucchelli C, Caruso E, Lavigna G, Erana H, Giachin G iScience. 2023; 26(9):107480.

PMID: 37636075 PMC: 10448035. DOI: 10.1016/j.isci.2023.107480.


Altered properties of amyloidogenic prion protein in genetic Creutzfeldt-Jakob disease with PRNP V180I mutation in response to pentosan polysulfate.

Shijo M, Yoshimura M, Omae T, Hashimoto G, Mizoguchi T, Kuwashiro T Brain Pathol. 2023; 33(5):e13197.

PMID: 37525413 PMC: 10467033. DOI: 10.1111/bpa.13197.


The Effect of Valeton (Zingiberaceae) Extract on Prion Propagation in Cell-Based and Animal Models.

Lee S, Lee H, Kim J, Kim J, Gao E, Lee Y Int J Mol Sci. 2023; 24(1).

PMID: 36613636 PMC: 9820341. DOI: 10.3390/ijms24010182.


References
1.
Ladogana A, Casaccia P, Ingrosso L, Cibati M, Salvatore M, Xi Y . Sulphate polyanions prolong the incubation period of scrapie-infected hamsters. J Gen Virol. 1992; 73 ( Pt 3):661-5. DOI: 10.1099/0022-1317-73-3-661. View

2.
Kisilevsky R . From arthritis to Alzheimer's disease: current concepts on the pathogenesis of amyloidosis. Can J Physiol Pharmacol. 1987; 65(9):1805-15. DOI: 10.1139/y87-282. View

3.
Rohwer R . The scrapie agent: "a virus by any other name". Curr Top Microbiol Immunol. 1991; 172:195-232. View

4.
Caughey B, Race R . Potent inhibition of scrapie-associated PrP accumulation by congo red. J Neurochem. 1992; 59(2):768-71. DOI: 10.1111/j.1471-4159.1992.tb09437.x. View

5.
Takemoto K, FABISCH P . INHIBITION OF HERPES VIRUS BY NATURAL AND SYNTHETIC ACID POLYSACCHARIDES. Proc Soc Exp Biol Med. 1964; 116:140-4. DOI: 10.3181/00379727-116-29183. View